Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04437615 · ClinicalTrials.gov registry record
Colorectal Polyp Clinical Decision Support Device Study
A clinical trial, sponsored by Olympus Corporation of the Americas.
- Completed
- Registry status
- 2,379
- Enrollment target
NCT04437615: Completed study, sponsored by Olympus Corporation of the Americas.
NCT04437615 is a clinical trial that has completed, run by Olympus Corporation of the Americas. The registered enrollment target is 2,379 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04437615 has completed, sponsored by Olympus Corporation of the Americas.
- COMPLETED
- Registry status
- 2,379 participants
- Enrollment target
Study Summary
The study objective is to establish the efficacy of the colorectal polyp Clinical Decision Support Device (CDSD) in clinical use.
Primary Outcome
CDSD-unaided and CDSD-aided predictions will be compared with the ground truth pathology results.
Interventions
- PROCEDURE Colonoscopy
- DEVICE Clinical Decision Support Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,379 participants |
| Start Date | 2020-11-05 |
| Est. Completion | 2023-03-30 |
What the finished NCT04437615 record still lists
NCT04437615 is an interventional study that assigns participants to a tested intervention. Its 2,379 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which Colonoscopy is the first listed.
NCT04437615 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04437615 about?
NCT04437615 is a clinical study titled "Colorectal Polyp Clinical Decision Support Device Study". The study objective is to establish the efficacy of the colorectal polyp Clinical Decision Support Device (CDSD) in clinical use.
What is the current status of trial NCT04437615?
This trial is currently completed. The enrollment target is 2,379 participants. The study started on 2020-11-05. Estimated completion is 2023-03-30.
What interventions are being tested in trial NCT04437615?
The interventions under investigation include: Colonoscopy (PROCEDURE), Clinical Decision Support Device (DEVICE).
Who is sponsoring clinical trial NCT04437615?
This trial is sponsored by Olympus Corporation of the Americas, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05868421 · 2,376 participants · NA
Veteran Social Support for Enhancing Use of Smoking Cessation Treatment
- NCT06747494 · 2,396 participants · NA
General vs Spinal in Total Joint Arthroplasty (TJA)
- NCT05185440 · 2,400 participants · NA
Reducing Alcohol Involved Sexual Violence in Higher Education
- NCT05285527 · 2,400 participants · NA
MiSight 1 Day Safety Post-Approval Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI